VeriMomnaringenin est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
Pregnancy-safe products containing naringenin
Related ingredients
Frequently asked questions
- naringenin est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
- naringenin est-il sûr pendant l'allaitement ?
- Same rationale as for pregnancy: no harmonised reproductive classification and no authoritative CIR/SCCS contraindication identified. Potential for low systemic absorption after topical use implies low measurable exposure in breastfeeding parent (e=1). No specific data on milk transfer were found in the authoritative sources consulted.
- naringenin est-il sûr pour la peau de bébé ?
- No infant‑specific developmental toxicity or dermal‑toxicity data indicating increased hazard. Following the specified instruction to increase exposure for infants when adult topical absorption is measurable, baby exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher permeability and greater surface‑area‑to‑weight ratio. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- Comment VeriMom évalue-t-il naringenin ?
- VeriMom évalue naringenin à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à naringenin pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à naringenin basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.